F383-0021 Screening compound: 5-[(1,3-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide

F383-0021 Screening compound: 5-[(1,3-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide
F383-0021 Screening compound: 5-[(1,3-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F383-0021
5-[(1,3-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F383-0021

Molecular Formula

C22H25N3O4S (C22 H25 N3 O4 S)

Compound Name

5-[(1,3-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide

IUPAC name

5-[(13-dioxo-octahydro-1H-isoindol-2-yl)methyl]-2-methyl-N-(5-methylpyridin-2-yl)benzene-1-sulfonamide

SMILES

Cc(cc1)cnc1NS(c1c(C)ccc(CN(C(C2C3CCCC2)=O)C3=O)c1)(=O)=O

InChI

InChI=1S/C22H25N3O4S/c1-14-7-10-20(23-12-14)24-30(28,29)19-11-16(9-8-15(19)2)13-25-21(26)17-5-3-4-6-18(17)22(25)27/h7-12,17-18H,3-6,13H2,1-2H3,(H,23,24)

InChI Key

LWURVRBYLYRRNF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14952353

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.226

Distribution Coefficient, logD

1.884

Water Solubility, LogSw

-3.41

Polar Surface Area

80.038

Acid Dissociation Constant (pKa)

6.08

Base Dissociation Constant (pKb)

2.47

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

40.90

F383-0021 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Proteases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with F383-0021 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F383-0021?
Check Price and Availability of F383-0021, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F383-0021 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F383-0021
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F383-0021
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F383-0021 available by request